Petros Pharmaceuticals (PTPI) President Fady Receives 375,000-Share Award

What Happened

Boctor Fady, President & Chief Commercial Officer of Petros Pharmaceuticals (PTPI), was granted 375,000 restricted shares on June 5, 2026. The shares were issued at $0.00 (grant award), so no cash was exchanged. Per the filing, 50% of the shares vested on the grant date and the remaining 50% will vest on the six‑month anniversary, subject to continued service.

Key Details

• Transaction date: 2026-06-05; Transaction code: A (award/grant)
• Shares granted: 375,000 restricted common shares; Price: $0.00; Total cash value shown: $0
• Vesting: 50% vested at grant; remaining 50% vests six months after grant, contingent on continued service (see footnote)
• Shares owned after transaction: Not disclosed in the Form 4 filing
• Filing timeliness: Reported on the same date (filed 2026-06-05), no late filing indicated

Context

These are restricted stock awards subject to a short vesting schedule and service condition, so they are not immediately free to trade beyond the vested portion. A grant at $0.00 is a compensation award rather than a purchase; it does not indicate an immediate cash investment by the insider.